An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma

Detalles Bibliográficos
Autores principales: Reggiani, Francesca, Sauta, Elisabetta, Torricelli, Federica, Zanetti, Eleonora, Tagliavini, Elena, Santandrea, Giacomo, Gobbi, Giulia, Damia, Giovanna, Bellazzi, Riccardo, Ambrosetti, Davide, Ciarrocchi, Alessia, Sancisi, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022436/
https://www.ncbi.nlm.nih.gov/pubmed/33823854
http://dx.doi.org/10.1186/s12943-021-01357-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022436/
https://www.ncbi.nlm.nih.gov/pubmed/33823854
http://dx.doi.org/10.1186/s12943-021-01357-z

Ejemplares similares